Since its outbreak in the last December, coronavirus disease 2019 (COVID-19) caused by
SARS-CoV-2 has rapidly spread worldwide at a pandemic proportion and thus is regarded …

Abstract Objective Many Computer Aided Prognostic (CAP) systems based on machine
learning techniques have been proposed in the field of oncology. The objective of this …

Epithelial ovarian cancer (EOC) is the leading cause of death among all gynecological
cancers. Morusin, a prenylated flavonoid extracted from the root bark of Morus australis, has …

Highlights•Epigenetic alterations are an emerging factor in colorectal carcinogenesis.•The
discovery of epigenetic pathways constitutes a major advance in cancer biomarker …

Background Ovarian cancer stem cells (OCSC), endowed with tumor-initiating and self-
renewal capacity, would account not only for the tumor growth, the peritoneal metastasis …

While the vaccination is now available to many countries and will slowly dissipate to others,
effective therapeutics for COVID-19 is still illusive. The SARS-CoV-2 pandemic has posed …

S100A10, which is also known as p11, is located in the plasma membrane and forms a
heterotetramer with annexin A2. The heterotetramer, comprising of two subunits of annexin …

Intrinsic or acquired drug resistance, adverse drug reactions and tumor heterogeneity
between and within cancer patients limit the efficacy of clinical management of advanced …

Until to date, platinum derived drugs are still the backbone of treating ovarian cancer (OC).
Most patients treated with platinum-based chemotherapy develop resistance during the …

TP53 mutation is considerably common in advanced high‐grade serous ovarian cancer
(HGSOC) and significantly associated with a poor prognosis. In this study, we investigated …